Ottava anchors the pre-market research tier of DEPLOY's surgical category. Under the FDA-clearance-as-gating-event framework, the gating event has not occurred, so Ottava is research tier regardless of who makes it.
💡
J&J is a household name, but DEPLOY treats Ottava at the same research tier as far smaller pre-market entrants. The framework does not grant credit for corporate scale; only the verified gating event (FDA clearance) moves an entity up a tier.
Price
No reviewed price is on record. We do not treat unverified analyst estimates as pricing data. There is no price: Ottava is not cleared and not marketed. DEPLOY records zero price points for a pre-market system.
Availability
Internal use only
Ottava is not available. J&J submitted a De Novo request to the FDA in January 2026; it is not authorized to be marketed, and there is no installed base.
Real-world status
Ottava, from J&J MedTech (Ethicon), is a soft-tissue general-surgery robotic platform with four arms integrated into the operating table, announced in 2020. It is pre-market: a De Novo request was submitted to the FDA in January 2026, and Ottava is not authorized to be marketed. DEPLOY classifies it research tier under the FDA-clearance-as-gating-event framework: J&J's corporate scale does not translate into verified surgical-robotics deployment, so Ottava sits at the same research tier as far smaller pre-market entrants. Surfacing that on a household-name corporate is the framework's discipline applied without exception.
✔
Ottava is a real J&J MedTech (Ethicon) platform: four arms integrated into the operating table, for soft-tissue general surgery, announced in 2020, with a De Novo request submitted to the FDA in January 2026.
⊘
Ottava is not cleared and not marketed: there is no installed base and no price. DEPLOY records the absence rather than treating J&J's scale or a submission as if it were a verified deployment.
No⊘absence. J&J submitted a De Novo request to the FDA in January 2026; Ottava is not authorized to be marketed.
Can I buy a J&J Ottava?
No⊘absence. Ottava is pre-market, not cleared and not marketed; there is no price or installed base.
What is J&J Ottava?
A soft-tissue general-surgery robot from J&J MedTech (Ethicon) with four arms integrated into the operating table🟢verified, announced in 2020.
Why does DEPLOY call Ottava research tier when J&J is huge?
Because the gating event (FDA clearance) has not occurred🟢verified. Corporate scale is not verified deployment; the framework treats Ottava the same as small pre-market entrants.
How does Ottava compare to da Vinci?
Da Vinci is verified-at-scale (11,395 installed)🟢verified; Ottava is pre-market with zero installed and no clearance, despite J&J's size.
Pricing and availability are tagged verified or claimed against primary sources. Manufacturer targets are reported as targets, not prices you can pay today.